<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26917423</PMID><DateCompleted><Year>2017</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2016</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Serological detection and analysis of anti-VP1 responses against various enteroviruses (EV) (EV-A, EV-B and EV-C) in Chinese individuals.</ArticleTitle><Pagination><StartPage>21979</StartPage><MedlinePgn>21979</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">21979</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep21979</ELocationID><Abstract><AbstractText>The overall serological prevalence of EV infections based on ELISA remains unknown. In the present study, the antibody responses against VP1 of the EV-A species (enterovirus 71 (EV71), Coxsackievirus A16 (CA16), Coxsackievirus A5 (CA5) and Coxsackievirus A6 (CA6)), of the EV-B species (Coxsackievirus B3 (CB3)), and of the EV-C species (Poliovirus 1 (PV1)) were detected and analyzed by a NEIBM (novel evolved immunoglobulin-binding molecule)-based ELISA in Shanghai blood donors. The serological prevalence of anti-CB3 VP1 antibodies was demonstrated to show the highest level, with anti-PV1 VP1 antibodies at the second highest level, and anti-CA5, CA6, CA16 and EV71 VP1 antibodies at a comparatively low level. All reactions were significantly correlated at different levels, which were approximately proportional to their sequence similarities. Antibody responses against EV71 VP1 showed obvious differences with responses against other EV-A viruses. Obvious differences in antibody responses between August 2013 and May 2014 were revealed. These findings are the first to describe the detailed information of the serological prevalence of human antibody responses against the VP1 of EV-A, B and C viruses, and could be helpful for understanding of the ubiquity of EV infections and for identifying an effective approach for seroepidemiological surveillance based on ELISA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Caixia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Yingying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jiaojiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Baohua</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Blood Transfusion, Changhai Hospital, Second Military Medical University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ziyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anhui Medical University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Chunyan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiangyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Mingmei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rui</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Parasitology, School of Basic Medicine, Second Military Medical University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000917" MajorTopicYN="Y">Antibody Formation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26917423</ArticleId><ArticleId IdType="pmc">PMC4768086</ArticleId><ArticleId IdType="doi">10.1038/srep21979</ArticleId><ArticleId IdType="pii">srep21979</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>King A. M., Adams M. J. &amp; Lefkowitz E. J. Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses. Vol. 9 (Elsevier, 2011), pp. 835&#x2013;839.</Citation></Reference><Reference><Citation>Tapparel C., Siegrist F., Petty T. J. &amp; Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 14, 282&#x2013;293, doi: 10.1016/j.meegid.2012.10.016 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2012.10.016</ArticleId><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W. et al. Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. The Lancet. Infectious diseases 14, 308&#x2013;318, doi: 10.1016/s1473-3099(13)70342-6 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X. et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008&#x2013;2013. Sci Rep 5, 8904, doi: 10.1038/srep08904 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep08904</ArticleId><ArticleId IdType="pmc">PMC4354091</ArticleId><ArticleId IdType="pubmed">25754970</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26, 91&#x2013;107 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva E. E., Winkler M. T. &amp; Pallansch M. A. Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis 2, 231&#x2013;233, doi: 10.3201/eid0203.960312 (1996).</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0203.960312</ArticleId><ArticleId IdType="pmc">PMC2626804</ArticleId><ArticleId IdType="pubmed">8903236</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Takatsy S., Kukan E., Mihaly I. &amp; Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol 71, 217&#x2013;227 (1982).</Citation><ArticleIdList><ArticleId IdType="pubmed">6285858</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuda G. M., Chang W. K., Yeung C. Y. &amp; Tang P. S. Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J 6, 206&#x2013;208 (1987).</Citation><ArticleIdList><ArticleId IdType="pubmed">3562141</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindarov L. M. et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol 23, 284&#x2013;295 (1979).</Citation><ArticleIdList><ArticleId IdType="pubmed">231067</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X. et al. The persistent circulation of enterovirus 71 in People&#x2019;s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 6, e25662, doi: 10.1371/journal.pone.0025662 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025662</ArticleId><ArticleId IdType="pmc">PMC3181342</ArticleId><ArticleId IdType="pubmed">21980521</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F. et al. Enterovirus 71 outbreak in the People&#x2019;s Republic of China in 2008. J Clin Microbiol 47, 2351&#x2013;2352, doi: 10.1128/jcm.00563-09 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.00563-09</ArticleId><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 7, 94, doi: 10.1186/1743-422x-7-94 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422x-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B. A. &amp; Pallansch M. A. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39, 195&#x2013;205 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. W., Kiang D., Smith D. J. &amp; Wang J. R. Evolution of re-emergent virus and its impact on enterovirus 71 epidemics. Experimental biology and medicine (Maywood, N.J.) 236, 899&#x2013;908, doi: 10.1258/ebm.2010.010233 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2010.010233</ArticleId><ArticleId IdType="pubmed">21715436</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuente J. O. et al. Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J Virol 87, 7637&#x2013;7645, doi: 10.1128/jvi.03519-12 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.03519-12</ArticleId><ArticleId IdType="pmc">PMC3700288</ArticleId><ArticleId IdType="pubmed">23637404</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R. J. &amp; Rossmann M. G. Crystal structure of human enterovirus 71. Science 336, 1274, doi: 10.1126/science.1218713 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P., Perera R., Cardosa J., Kuhn R. J. &amp; Rossmann M. G. Structure determination of enterovirus 71. Acta crystallographica. Section D, Biological crystallography 68, 1217&#x2013;1222, doi: 10.1107/s0907444912025772 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/s0907444912025772</ArticleId><ArticleId IdType="pmc">PMC3489104</ArticleId><ArticleId IdType="pubmed">22948923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J. et al. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity. J Virol 89, 10500&#x2013;10511, doi: 10.1128/jvi.01102-15 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01102-15</ArticleId><ArticleId IdType="pmc">PMC4580203</ArticleId><ArticleId IdType="pubmed">26269176</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Y. Y., Chen Y. C. &amp; Lin T. H. Structure of the virus capsid protein VP1 of enterovirus 71 predicted by some homology modeling and molecular docking studies. J Comput Chem 27, 1556&#x2013;1570, doi: 10.1002/jcc.20460 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20460</ArticleId><ArticleId IdType="pubmed">16868986</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Wang H., Shih S. R., Chen T. C. &amp; Li M. L. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases. Curr Med Chem 14, 847&#x2013;856 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17430140</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitton J. L., Cornell C. T. &amp; Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nature reviews. Microbiology 3, 765&#x2013;776, doi: doi: 10.1038/nrmicro1284 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1284</ArticleId><ArticleId IdType="pubmed">16205710</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry E. E. et al. Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. The Journal of general virology 86, 1909&#x2013;1920, doi: 10.1099/vir.0.80730-0 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80730-0</ArticleId><ArticleId IdType="pubmed">15958669</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry E. et al. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure 7, 1527&#x2013;1538 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10647183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X. et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol 19, 424&#x2013;429, doi: 10.1038/nsmb.2255 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu X., Wang Y., Zhu F. &amp; Chen F. Two models for changes of EV71 immunity in infants and young children. Hum Vaccin Immunother 11, 1429&#x2013;1433, doi: 10.1080/21645515.2015.1016667 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1016667</ArticleId><ArticleId IdType="pmc">PMC4514399</ArticleId><ArticleId IdType="pubmed">25906390</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande J. M. et al. Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh. The Journal of infectious diseases 210 Suppl 1, S225&#x2013;233, doi: 10.1093/infdis/jiu204 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu204</ArticleId><ArticleId IdType="pmc">PMC10325558</ArticleId><ArticleId IdType="pubmed">25316839</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W. et al. Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period. PLoS One 8, e80515, doi: 10.1371/journal.pone.0080515 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080515</ArticleId><ArticleId IdType="pmc">PMC3850913</ArticleId><ArticleId IdType="pubmed">24324604</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahl S. et al. Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India. The Journal of infectious diseases 210 Suppl 1, S243&#x2013;251, doi: 10.1093/infdis/jit492 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit492</ArticleId><ArticleId IdType="pubmed">25316842</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y. et al. Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA. Sci Rep 5, 10636, doi: 10.1038/srep10636 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep10636</ArticleId><ArticleId IdType="pmc">PMC4448526</ArticleId><ArticleId IdType="pubmed">26023863</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi F. S. et al. Coxsackievirus B3 replication and pathogenesis. Future Microbiol 10, 629&#x2013;653, doi: 10.2217/fmb.15.5 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino T. A., Liu P. &amp; Sole M. J. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74, 182&#x2013;188 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8293557</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Tracy N. M. Chapman. Group B coxsackievirus diseases. Ehrenfeld E., Domingo E. &amp; Roos R. P. The picornaviruses. (American Society for Microbiology Press, 2010) pp. 353&#x2013;368.</Citation></Reference><Reference><Citation>Jiang S. H. et al. Alternate arrangement of PpL B3 domain and SpA D domain creates synergistic double-site binding to VH3 and Vkappa regions of fab. DNA Cell Biol 27, 423&#x2013;431, doi: 10.1089/dna.2007.0708 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2007.0708</ArticleId><ArticleId IdType="pubmed">18694300</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J. et al. Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus. PLoS One 6, e18477, doi: 10.1371/journal.pone.0018477 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0018477</ArticleId><ArticleId IdType="pmc">PMC3077374</ArticleId><ArticleId IdType="pubmed">21533225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P. et al. A simple, universal, efficient PCR-based gene synthesis method: sequential OE-PCR gene synthesis. Gene 524, 347&#x2013;354, doi: 10.1016/j.gene.2013.03.126 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2013.03.126</ArticleId><ArticleId IdType="pubmed">23597923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q. et al. Characterization of Tat antibody responses in Chinese individuals infected with HIV-1. PLoS One 8, e60825, doi: 10.1371/journal.pone.0060825 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0060825</ArticleId><ArticleId IdType="pmc">PMC3614898</ArticleId><ArticleId IdType="pubmed">23565278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota J., Shimoji Y. &amp; Shimizu S. New sensitive competitive enzyme-linked immunosorbent assay using a monoclonal antibody against nonstructural protein 1 of West Nile virus NY99. Clinical and vaccine immunology: CVI 19, 277&#x2013;283, doi: 10.1128/cvi.05382-11 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cvi.05382-11</ArticleId><ArticleId IdType="pmc">PMC3272939</ArticleId><ArticleId IdType="pubmed">22190400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mythili T., Rajendra L., Bhavesh T., Thiagarajan D. &amp; Srinivasan V. A. Development and comparative evaluation of a competitive ELISA with rose bengal test and a commercial indirect ELISA for serological diagnosis of brucellosis. Indian J Microbiol 51, 528&#x2013;530, doi: 10.1007/s12088-011-0151-0 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12088-011-0151-0</ArticleId><ArticleId IdType="pmc">PMC3209930</ArticleId><ArticleId IdType="pubmed">23024418</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma N. et al. Detection of Francisella tularensis-specific antibodies in patients with tularemia by a novel competitive enzyme-linked immunosorbent assay. Clinical and vaccine immunology: CVI 20, 9&#x2013;16, doi: 10.1128/cvi.00516-12 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cvi.00516-12</ArticleId><ArticleId IdType="pmc">PMC3535769</ArticleId><ArticleId IdType="pubmed">23114700</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>